These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20877305)

  • 1. Living donor kidney transplantation in patients with hereditary nephropathies.
    Niaudet P
    Nat Rev Nephrol; 2010 Dec; 6(12):736-43. PubMed ID: 20877305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplantation in patients with hereditary kidney disease: our experience.
    Mazzarella V; Splendiani G; Tozzo C; Tisone G; Pisani F; Iaria G; Casciani CU
    Contrib Nephrol; 1997; 122():203-6. PubMed ID: 9399068
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.
    Petzold F; Bachmann A; Bergmann C; Helmchen U; Halbritter J
    BMC Nephrol; 2019 Sep; 20(1):340. PubMed ID: 31477057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis and clinical course of hereditary nephropathies].
    Lhotta K
    Acta Med Austriaca; 2001; 28(3):78-80. PubMed ID: 11475106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anesthetic management of Schimke syndrome.
    Yıldırım Güçlü C; Selvi Can O; Ozçelik M
    J Anesth; 2014 Oct; 28(5):797. PubMed ID: 24474620
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary Renal Diseases.
    Mehta L; Jim B
    Semin Nephrol; 2017 Jul; 37(4):354-361. PubMed ID: 28711074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome.
    Gross O; Weber M; Fries JW; Müller GA
    Nephrol Dial Transplant; 2009 May; 24(5):1626-30. PubMed ID: 19028755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living-Related Kidney Transplantation in a Patient with Juvenile Nephronophthisis.
    Vnučák M; Graňák K; Skálová P; Laca Ľ; Mokáň M; Dedinská I
    Nephron; 2020; 144(11):583-588. PubMed ID: 32906116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of a Human Laminin
    Funk SD; Bayer RH; Malone AF; McKee KK; Yurchenco PD; Miner JH
    J Am Soc Nephrol; 2018 Mar; 29(3):949-960. PubMed ID: 29263159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation in a child with Pierson syndrome.
    Guler S; Cimen S; Acott P; Whelan K; Molinari M
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 29094445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing in the assessment of living related kidney donors at risk of autosomal dominant polycystic kidney disease.
    Simms RJ; Travis DL; Durkie M; Wilson G; Dalton A; Ong AC
    Transplantation; 2015 May; 99(5):1023-9. PubMed ID: 25340609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Follow-Up of Kidney Transplant Recipients With Polycystic Kidney Disease.
    Mehrabi A; Golriz M; Maier J; Fonouni H; Garoussi C; Hafezi M; Fard N; Faridar A; Rezaei N; Wiesel M; Mieth M; Morath C; Büchler MW; Tönshoff B; Zeier M; Schmidt J; Schemmer P
    Exp Clin Transplant; 2015 Oct; 13(5):413-20. PubMed ID: 26450465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease.
    Wagner MD; Prather JC; Barry JM
    J Urol; 2007 Jun; 177(6):2250-4; discussion 2254. PubMed ID: 17509331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal transplantation from living donor parents in two brothers with Alport syndrome. Can asymptomatic female carriers of the Alport gene be accepted as kidney donors?
    Sessa A; Pietrucci A; Carozzi S; Torri Tarelli L; Tazzari S; Giordano F; Meroni M; Battini G; Valente U; Renieri A
    Nephron; 1995; 70(1):106-9. PubMed ID: 7617088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease.
    Huang E; Samaniego-Picota M; McCune T; Melancon JK; Montgomery RA; Ugarte R; Kraus E; Womer K; Rabb H; Watnick T
    Transplantation; 2009 Jan; 87(1):133-7. PubMed ID: 19136903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living related kidney transplantation in a patient with autosomal-recessive Alport syndrome.
    Sakai K; Muramatsu M; Ogiwara H; Kawamura T; Arai K; Aikawa A; Ohara T; Mizuiri S; Joh K; Naito I; Hasegawa A
    Clin Transplant; 2003; 17 Suppl 10():4-8. PubMed ID: 12823249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of monogenic chronic kidney diseases.
    Armstrong ME; Thomas CP
    Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):183-194. PubMed ID: 30601180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.
    Caliskan Y; Lentine KL
    Pediatr Nephrol; 2022 Sep; 37(9):1981-1994. PubMed ID: 35088158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia.
    Bertaina A; Grimm PC; Weinberg K; Parkman R; Kristovich KM; Barbarito G; Lippner E; Dhamdhere G; Ramachandran V; Spatz JM; Fathallah-Shaykh S; Atkinson TP; Al-Uzri A; Aubert G; van der Elst K; Green SG; Agarwal R; Slepicka PF; Shah AJ; Roncarolo MG; Gallo A; Concepcion W; Lewis DB
    N Engl J Med; 2022 Jun; 386(24):2295-2302. PubMed ID: 35704481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing Strategy.
    Thomas CP; Mansilla MA; Sompallae R; Mason SO; Nishimura CJ; Kimble MJ; Campbell CA; Kwitek AE; Darbro BW; Stewart ZA; Smith RJ
    Am J Transplant; 2017 Feb; 17(2):401-410. PubMed ID: 27434427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.